Alternatives to Covalenttoxin
Covalenttoxin is a AI-Driven Drug Discovery tool: aI-driven platform for accelerating the discovery and design of novel toxins and therapeutic molecules. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
Covalenttoxin profileOpen source alternatives (10)More AI-Driven Drug Discovery alternatives
The 20 closest AI-Driven Drug Discovery companies to Covalenttoxin
- Website Immunes41AI-Driven Drug Discovery$16.0M
- Website AIAiomics29AI-Driven Drug DiscoverySan Francisco, United States$3.7M
- Website MOMoa Technology54AI-Driven Drug DiscoveryLondon, United Kingdom$28.0M
Develops AI-powered tools for scientific research and discovery, focusing on drug discovery and materials science.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
CytoReason68HealthcareTel Aviv, Israel$128.3MDevelops a computational model of the human body for drug discovery and development.
- Website
Isomorphic Labs68Drug DiscoveryLondon, United Kingdom$4.7BAI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
BenchSci64BiotechToronto, Canada$197.3MAI-powered platform for understanding disease biology and accelerating drug discovery.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website
DeepCure63HealthcareTel Aviv, Israel$65.4MAI-driven drug discovery platform accelerating breakthrough scientific research.
- Website
Insitro62HealthcareSouth San Francisco, United States$243.0MData-driven drug discovery and development company using machine learning and high-throughput biology.
- Website
Deep Genomics61BiotechToronto, Canada$241.0MAI-powered biotechnology company developing RNA therapeutics for genetic diseases.
- Website
Iambic Therapeutics61BiotechSan Diego, United States$50.0MAI-driven drug discovery company developing novel medicines for unmet patient needs.
- Website
Algorithmiq60Quantum ComputingHelsinki, Finland$38.1MQuantum software company enabling breakthroughs in chemistry, materials science, and life sciences.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website ARArcaScience39AI-Driven Drug DiscoverySan Francisco, United States$16.0M
- Website
Mana.bio59Life SciencesBoston, United States$19.5MAI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
- Website
Quris59HealthcareTel Aviv, Israel$37.0MAI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.
- Website
TrialJectory58HealthcareNew York, United States$39.7MAI-powered platform connecting cancer patients to advanced treatments and clinical trials.
- Website
Remepy57HealthcareTel Aviv, Israel$15.0MDigital therapeutics platform enhancing drug efficacy and safety through personalized software.
Showing the 20 closest matches. See the rest on the Covalenttoxin profile.
Compare Covalenttoxin head to head
Side by side on what each one does, what it costs, and what real users report.